natürliche glp 1 agonisten GLP1-Agonisten bei Hautleiden: Hoffnung oder Hype? GLP-1 Supplement | Bestes GLP-1

11 However, a dose-specific analysis revealed that the beneficial effect of efpeglenatide on HF hospitalisation was primarily seen in the 6 mg group, in which there was a 50% RRR in HF hospitalisation (HR 0.50)

The cardiovascular protection offered by GLP-1 receptor agonists stems from several complementary mechanisms: Anti-inflammatory effects through suppression of CRP, TNF-, and other inflammatory markers Substantial weight reduction, particularly with higher doses of newer agents Blood pressure modulation via direct vascular effects and enhanced natriuresis Improved endothelial function and lipid profiles Renal protective effects, including reduced albuminuria and slowed eGFR decline Though initially established in type 2 diabetes populations, recent evidence from the SELECT trial confirms these benefits extend to non-diabetic patients with obesity and established cardiovascular disease

Timothy Garvey, MD, professor of medicine and director of the University of Alabama at Birminghams Diabetes Research Center

Understanding the science helps us move past the "trend" and focus on the health transformation

Diabetes 58: 2148-2161, 2009

[DOI] [PubMed] [Google Scholar] 4